Matched sample comparison of intramuscular versus vaginal micronized progesterone for prevention of preterm birth

References

• Beck S, Wojdyla D, Say L, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 2010;88:31–8
   PubMed Web of Science ®Google Scholar
• Fukuyama A, Tanaka K, Kakizaki L, et al. Anti-inflammatory effect of proteoglycan and progesterone on human uterine cervical fibroblasts. Life Sciences 2012;90:484–8
   PubMed Web of Science ®Google Scholar
• Smith V, Devane D, Begley CM, et al. A systematic review and quality assessment of systematic reviews of randomized trials of interventions for preventing and treating preterm birth. Eur J Obstet Gynecol Reprod Biol 2009;142:3–11
   PubMed Web of Science ®Google Scholar
• Grazzini E, Guillon G, Mouillac B, Zingg HH. Inhibition of oxytocin receptor functions by direct binding of progesterone. Nature 1998;392:509–12
   PubMed Web of Science ®Google Scholar
• De Ziegler D, Bulletti C, Fanchin R, et al. Contractility of the non-pregnant uterus: the follicular phase. Ann NY Acad Sci 2001;943:172–84
   PubMedGoogle Scholar
• Lopez BA. Mechanisms of labour – biochemical aspects. BJOG 2003;110:39–45
   Google Scholar
• Pepe GJ, Albrecht ED. Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev 1995;16:608–48
   PubMed Web of Science ®Google Scholar
• Csapo AL. Progesterone “block”. Am J Anat 1956;98:273–92
   PubMedGoogle Scholar
• Mesiano S. Myometrial progesterone responsiveness and the control of human parturition. J Soc Gynecol Investig 2004;11:193–202
   PubMedGoogle Scholar
• Astle S, Slater DM, Thornton S. The involvement of progesterone in the onset of human labour. Eur J Obstet Gynecol Reprod Biol 2003;108:177–81
   PubMed Web of Science ®Google Scholar
• Martin JA, Hamilton BE, Sutton PD. For the centers for disease control and prevention national center for health statistics national vital statistics system. Births: final data for 2005. Natl Vital Stat Rep 2007;56:1–103
   PubMedGoogle Scholar
• da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003;188:419–24
   PubMed Web of Science ®Google Scholar
• Rouse DJ, Caritis SN, Peaceman AM, et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 2007;357:454–61
   PubMed Web of Science ®Google Scholar
• Rode L, Langhoff-Roos J, Andersson C, et al. Systematic review of progesterone for the prevention of preterm birth in singleton pregnancies. Acta Obstet Gynecol Scand 2009;88:1180–9
   PubMed Web of Science ®Google Scholar
• Mackenzie R, Walker M, Armson A, Hannah ME. Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol 2006;194:1234–42
   PubMed Web of Science ®Google Scholar
• Cetingoz E, Cam C, Sakall M, et al. Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial. Arch Gynecol Obstet 2011;2:423–9
   Google Scholar
• Berghella V, Figueroa D, Szychowski JM, et al. 17-Alphahydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length. Am J Obstet Gynecol 2010;202:e1–6
   PubMedGoogle Scholar
• Kelly RW. Pregnancy maintenance and parturition: the role of prostaglandin in manipulating the immune and inflammatory response. Endocr Rev 1994;15:684–706
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Dante G, Venturini P, et al. 17-Alpha-hydroxyprogesterone effects on cervical proinflammatory agents in women at risk for preterm delivery. Am J Perinatol 2008;25:503–6
   PubMed Web of Science ®Google Scholar
• Meis PJ, Klebanoff M, Thom E, et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003;348:2379–85
   PubMed Web of Science ®Google Scholar
• Fonseca EB, Celik E, Parra M, et al. Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007;357:462–9
   PubMed Web of Science ®Google Scholar
• Abd El Hameed AA. Vaginal versus intramuscular progesterone in the prevention of preterm labor and their effect on uterine and fetal blood flow. Middle East Fertility Soc J 2012;17:163--9
   Google Scholar